Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder

被引：0
|
作者：
Nandita Kachru
Sneha Sura
Satabdi Chatterjee
Rajender R. Aparasu
机构：
[1] University of Houston,Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy
[2] Texas Medical Center,undefined
来源：
Drugs & Aging | 2016年 / 33卷
关键词：
Oxybutynin; Tolterodine; Pelvic Floor Muscle Training; Solifenacin; Mirabegron;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：755 / 763
页数：8
相关论文
共 50 条
  • [31] Re: Antimuscarinic Drug Therapy for Overactive Bladder Syndrome in the Elderly-Are the Concerns Justified?
    Wein, Alan J.
    [J]. JOURNAL OF UROLOGY, 2019, 202 (06): : 1103 - 1104
  • [32] Is imidafenacin an alternative to current antimuscarinic drugs for patients with overactive bladder syndrome?
    Jia-Pei Wu
    Liao Peng
    Xiao Zeng
    Hao Li
    Hong Shen
    De-Yi Luo
    [J]. International Urogynecology Journal, 2021, 32 : 1117 - 1127
  • [33] Cost analysis of overactive bladder treatments for oral antimuscarinic refractory patients
    Watanabe, Jonathan H.
    Campbell, Jonathan D.
    Ravelo, Arliene
    Chancellor, Michael B.
    Kowalski, Jonathan W.
    Sullivan, Sean D.
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 55 - 56
  • [34] Effect of treatment response on the decision to escalate antimuscarinic dose in elderly subjects with overactive bladder
    Wagg, A.
    Khullar, V
    Oelke, M.
    Marschall-Kehrel, D.
    Michel, M. C.
    Darekar, A.
    Ebel-Bitoun, C.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E578 - U241
  • [35] Persistence and concomitant medication in patients with overactive bladder treated with antimuscarinic agents in primary care. An observational baseline study
    Sicras-Mainar, A.
    Navarro-Artieda, R.
    Ruiz-Torrejon, A.
    Saez-Zafra, M.
    Coll-de Tuero, G.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (02): : 96 - 101
  • [36] Overactive Bladder Medication Adherence When Medication is Free to Patients
    Sears, Christine L. G.
    Lewis, Christa
    Noel, Kathleen
    Albright, Todd S.
    Fischer, John R.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (03): : 1077 - 1081
  • [37] Limitations to antimuscarinic use in nursing home residents with overactive bladder and/or urinary incontinence
    Zarowitz, Barbara
    Allen, Carrie
    O'Shea, Terrence
    Berner, Todd
    Tangalos, Eric
    Ouslander, Joseph
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E190 - E191
  • [38] Patterns of Use of Antimuscarinic Drugs for Overactive Bladder: A Study of the Norwegian Prescription Database
    Mauseth, Siri Ann
    Spigset, Olav
    Skurtveit, Svetlana
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 66 - 67
  • [39] Listening to the patient: a flexible approach to the use of antimuscarinic agents in overactive bladder syndrome
    Chapple, Christopher R.
    Rosenberg, Matt T.
    Brenes, Francisco J.
    [J]. BJU INTERNATIONAL, 2009, 104 (07) : 960 - 967
  • [40] Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder
    Suehs, Brandon T.
    Davis, Cralen
    Franks, Billy
    Yuran, Thomas E.
    Ng, Daniel
    Bradt, Jason
    Knispel, John
    Vassilakis, Maria
    Berner, Todd
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (04) : 779 - 787
12345